Inventor · disambiguated record
Justin Klee
Also filed as: KLEE JUSTIN · KLEE JUSTIN BERNARD
9 granted patents·22 pending applications·48 citations·filing 2013–2025
87Inventor score
Files withAMYLYX PHARMACEUTICALS INC31
Top patents by PatentIndex Score
31 records- 0194US10857162B2Compositions for improving cell viability and methods of use thereofAMYLYX PHARMACEUTICALS INC·Filed 2020·Granted Dec 8, 2020·6 cites·22 claims
- 0293US11071742B2Compositions for improving cell viability and methods of use thereofAMYLYX PHARMACEUTICALS INC·Filed 2019·Granted Jul 27, 2021·6 cites·26 claims
- 0392US10251896B2Compositions for improving cell viability and methods of use thereofAMYLYX PHARMACEUTICALS INC·Filed 2017·Granted Apr 9, 2019·14 cites·15 claims
- 0491US11559533B2Compositions of bile acids and phenylbutyrate compoundsAMYLYX PHARMACEUTICALS INC·Filed 2021·Granted Jan 24, 2023·2 cites·18 claims
- 0591US9872865B2Compositions for improving cell viability and methods of use thereofAMYLYX PHARMACEUTICALS INC·Filed 2013·Granted Jan 23, 2018·19 cites·14 claims
- 0687US2025275985A1Compositions for improving cell viability and methods of use thereofAMYLYX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0782US11583542B2Compositions of bile acids and phenylbutyrate compoundsAMYLYX PHARMACEUTICALS INC·Filed 2020·Granted Feb 21, 2023·1 cites·21 claims
- 0878US12246027B2Compositions of bile acids and phenylbutyrate compoundsAMYLYX PHARMACEUTICALS INC·Filed 2022·Granted Mar 11, 2025·0 cites·11 claims
- 0978US12186330B2Compositions for improving cell viability and methods of use thereofAMYLYX PHARMACEUTICALS INC·Filed 2021·Granted Jan 7, 2025·0 cites·26 claims
- 1077US2022152056A1Methods and compositions for treating various disordersAMYLYX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1177US2022152058A1Methods and compositions for treating various disordersAMYLYX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1277US2022152059A1Methods and compositions for treating various disordersAMYLYX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1377US2022152054A1Methods and compositions for treating various disordersAMYLYX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1477US2022152057A1Methods and compositions for treating various disordersAMYLYX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1577US2022152053A1Methods and compositions for treating various disordersAMYLYX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1677US2022152052A1Methods and compositions for treating various disordersAMYLYX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1777US2022152055A1Methods and compositions for treating various disordersAMYLYX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1877US2022110948A1Compositions for improving cell viability and methods of use thereofAMYLYX PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1972US2025057856A1Methods and compositions for treating amyotrophic lateral sclerosisAMYLYX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2071US12138272B2Methods and compositions for treating amyotrophic lateral sclerosisAMYLYX PHARMACEUTICALS INC·Filed 2022·Granted Nov 12, 2024·0 cites·11 claims
- 2171US2021186990A1Methods and compositions for treating various disordersAMYLYX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2270US2020230156A1Compositions for improving cell viability and methods of use thereofAMYLYX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2368US2024102018A1Oligonucleotide compositions and methods thereofAMYLYX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2467US2024102017A1Oligonucleotide compositions and methods thereofAMYLYX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2566US2025032514A1Compositions and methods for the treatment of various diseasesAMYLYX PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2666US2025222010A1Compositions of bile acids and phenylbutyrate compoundsAMYLYX PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2763US2024139211A1Methods and compositions for treating amyotrophic lateral sclerosisAMYLYX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2863US2024100069A1Methods and Compositions for Treating Amyotrophic Lateral SclerosisAMYLYX PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2960US2025017946A1Combination of a bile acid and a phenyl butyrate compound for the treatment of neurodegenerative diseasesAMYLYX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3058US2023372263A1Methods and compositions for treating amyotrophic lateral sclerosisAMYLYX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3157US2023277630A1Methods and compositions for treating amyotrophic lateral sclerosisAMYLYX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Justin Klee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →